Follow The Filings

HCAT Health Catalyst

Health Catalyst earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by HCAT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HCAT insider trades
  • $105K bought by 1 insider
  • $128K sold by 1 insider outside a trading plan
  • $72K sold by 1 insider under 10b5-1 plans
  1. Simeon Kohl CEO
    Buy
    $105K 59,000 shares at $1.79 +2.1% to stake
    Traded Sep 14 Filed Sep 16
  2. Benjamin Landry General Counsel
    Planned sale
    $72K 27,425 shares at $2.64 22% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
  3. Julie Larson-Green Director
    Sale
    $128K 47,997 shares at $2.67 40% of stake
    Traded Dec 4, 2025 Filed Dec 9, 2025

Also filed in the last 12 months, not counted as buying or selling: 24 share withholdings for taxes and 22 stock grants.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
SCHEDULE 13D/A —
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
8-K 1.02,2.01,2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 5.07
SCHEDULE 13D —
SCHEDULE 13D/A —
8-K 1.01,7.01,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02,7.01,9.01
10-K/A
8-K 5.02,8.01,9.01
8-K 5.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.